Aglaris is a technology developer and provider that focuses on novel technologies for cell therapy manufacturing. Aglaris’ proprietary and transformative technology addresses critical weaknesses in the process development and manufacturing of T cell and other cell-based therapeutics. On top of its high-performance cell culture geometry, Aglaris is delivering CMC / PAT / Real-time Monitoring & Management to cell manufacturing. Both things together define a new generation of autonomous cell manufacturing equipment.
The company is led by industry experts, Mr. Steve Docksey, Dr David Horna and Dr Miquel Costa, who manage a growing international team with top engineers and scientists. Aglaris is located in state-of-the-art facilities and equipment at two technology parks: Stevenage Bioscience Catalyst in Stevenage, UK, and QUBE Technology Park in Madrid, Spain.